Compugen Ltd. (CGEN)
2.13
+0.01
(+0.47%)
USD |
NASDAQ |
Oct 09, 16:00
2.13
0.00 (0.00%)
After-Hours: 20:00
Compugen Enterprise Value : 79.49M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 79.49M |
| October 08, 2026 | 78.54M |
| October 07, 2026 | 81.38M |
| October 06, 2026 | 88.01M |
| October 05, 2026 | 96.54M |
| October 02, 2026 | 96.54M |
| October 01, 2026 | 99.38M |
| September 30, 2026 | 103.17M |
| September 29, 2026 | 100.32M |
| September 28, 2026 | 98.43M |
| September 25, 2026 | 103.17M |
| September 24, 2026 | 102.22M |
| September 23, 2026 | 99.38M |
| September 22, 2026 | 113.59M |
| September 21, 2026 | 108.38M |
| September 18, 2026 | 113.59M |
| September 17, 2026 | 110.74M |
| September 16, 2026 | 106.01M |
| September 15, 2026 | 106.01M |
| September 14, 2026 | 112.64M |
| September 11, 2026 | 111.69M |
| September 10, 2026 | 110.74M |
| September 09, 2026 | 112.64M |
| September 08, 2026 | 120.22M |
| September 04, 2026 | 123.06M |
| Date | Value |
|---|---|
| September 03, 2026 | 119.74M |
| September 02, 2026 | 126.85M |
| September 01, 2026 | 123.06M |
| August 31, 2026 | 120.22M |
| August 28, 2026 | 124.01M |
| August 27, 2026 | 139.16M |
| August 26, 2026 | 146.74M |
| August 25, 2026 | 149.58M |
| August 24, 2026 | 123.06M |
| August 21, 2026 | 125.43M |
| August 20, 2026 | 128.74M |
| August 19, 2026 | 108.85M |
| August 18, 2026 | 103.17M |
| August 17, 2026 | 100.32M |
| August 14, 2026 | 106.01M |
| August 13, 2026 | 106.01M |
| August 12, 2026 | 114.53M |
| August 11, 2026 | 105.06M |
| August 10, 2026 | 99.38M |
| August 07, 2026 | 106.01M |
| August 06, 2026 | 95.59M |
| August 05, 2026 | 93.69M |
| August 04, 2026 | 103.17M |
| August 03, 2026 | 103.17M |
| July 31, 2026 | 100.32M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Pluri, Inc. | 43.00M |
| Evogene Ltd. | 6.981M |
| Scinai Immunotherapeutics Ltd. | 7.027M |
| CollPlant Biotechnologies Ltd. | 4.779M |
| Regentis Biomaterials Ltd. | 53.61M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.006M |
| Revenue (Quarterly) | 2.602M |
| Total Expenses (Quarterly) | 9.608M |
| EPS Diluted (Quarterly) | -0.074 |
| Gross Profit Margin (Quarterly) | -3.54% |
| Profit Margin (Quarterly) | -269.3% |
| Earnings Yield | 17.39% |
| Operating Earnings Yield | 15.07% |
| Normalized Earnings Yield | 17.39 |